Cargando…

Antibody Therapy for Pediatric Leukemia

Despite increasing cure rates for pediatric leukemia, relapsed disease still carries a poor prognosis with significant morbidity and mortality. Novel targeted therapies are currently being investigated in an attempt to reduce adverse events and improve survival outcomes. Antibody therapies represent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vedi, Aditi, Ziegler, David S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000992/ https://www.ncbi.nlm.nih.gov/pubmed/24795859 http://dx.doi.org/10.3389/fonc.2014.00082

Ejemplares similares

Targeted Nanoparticles for Pediatric Leukemia Therapy
por: Basha, Riyaz, et al.
Publicado: (2014)

Antibody Therapy of Pediatric B-Cell Lymphoma
por: Meyer-Wentrup, Friederike, et al.
Publicado: (2013)

Immunotherapy for Pediatric Leukemia
por: Shah, Nirali N., et al.
Publicado: (2013)

Inhibitor of Apoptosis Proteins in Pediatric Leukemia: Molecular Pathways and Novel Approaches to Therapy
por: Fulda, Simone
Publicado: (2014)

Targeted Drug Discovery for Pediatric Leukemia
por: Napper, Andrew D., et al.
Publicado: (2013)

Murine Models of Acute Leukemia: Important Tools in Current Pediatric Leukemia Research
por: Jacoby, Elad, et al.
Publicado: (2014)

The Biology and Targeting of FLT3 in Pediatric Leukemia
por: Annesley, Colleen E., et al.
Publicado: (2014)

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
por: Tasian, Sarah K., et al.
Publicado: (2014)

Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications
por: Hoffman, Lindsey M., et al.
Publicado: (2014)

Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
por: Bernt, Kathrin M., et al.
Publicado: (2014)

Challenges of Clinical Trial Design for Targeted Agents Against Pediatric Leukemias
por: Mussai, Francis Jay, et al.
Publicado: (2015)

Case Report: Blinatumomab as upfront consolidation and maintenance therapy in a pediatric patient with high-risk B-cell acute lymphoblastic leukemia
por: Gupta, Sumit, et al.
Publicado: (2023)

Editorial: Microenvironment and therapy-resistance in leukemias
por: Friedmann, Rachel, et al.
Publicado: (2023)

The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Noronha, Elda Pereira, et al.
Publicado: (2019)

Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
por: Cerchione, Claudio, et al.
Publicado: (2021)

Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers
por: Duffy, Caitlyn, et al.
Publicado: (2023)

Advantages and Limitations of SNP Array in the Molecular Characterization of Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Lejman, Monika, et al.
Publicado: (2020)

Corrigendum: The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Noronha, Elda Pereira, et al.
Publicado: (2021)

Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients
por: Chaudhary, Shilpi, et al.
Publicado: (2023)

Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale
por: Masetti, Riccardo, et al.
Publicado: (2023)

Debating Frontline Therapy in Chronic Myeloid Leukemia
por: Bi, Xia, et al.
Publicado: (2021)

Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia
por: Varadarajan, Indumathy, et al.
Publicado: (2022)

Case report: A rare case of pulmonary mucormycosis caused by Lichtheimia ramosa in pediatric acute lymphoblastic leukemia and review of Lichtheimia infections in leukemia
por: He, Guo-qian, et al.
Publicado: (2022)

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies
por: Kent, Thomas, et al.
Publicado: (2020)

Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
por: Wang, Yin, et al.
Publicado: (2021)

Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study
por: Chu, Jinhua, et al.
Publicado: (2022)

CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia
por: Pasvolsky, Oren, et al.
Publicado: (2022)

Proton therapy for pediatric diencephalic tumors
por: Grippin, Adam J., et al.
Publicado: (2023)

Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition
por: Suknuntha, Kran, et al.
Publicado: (2020)

Acute Myeloid Leukemia as a Model for Cancer Therapy
por: Ravandi, Farhad
Publicado: (2012)

Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children’s Leukemia Group
por: Qiu, Kun-yin, et al.
Publicado: (2021)

Bioinformatic Description of Immunotherapy Targets for Pediatric T-Cell Leukemia and the Impact of Normal Gene Sets Used for Comparison
por: Orentas, Rimas J., et al.
Publicado: (2014)

Triple-hit explanation for the worse prognosis of pediatric acute lymphoblastic leukemia among Mexican and Hispanic children
por: Rivera-Luna, Roberto, et al.
Publicado: (2022)

Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy
por: Panina, Svetlana B., et al.
Publicado: (2020)

The Role of Metabolism in the Development of Personalized Therapies in Acute Myeloid Leukemia
por: Dembitz, Vilma, et al.
Publicado: (2021)

Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces
por: Gallardo-Pérez, Moisés M., et al.
Publicado: (2023)

CAR T Cell Therapy for Pediatric Brain Tumors
por: Patterson, John D., et al.
Publicado: (2020)

Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation
por: Mu, Hui, et al.
Publicado: (2021)

Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2016)

CD44 Expression Profile Varies According to Maturational Subtypes and Molecular Profiles of Pediatric T-Cell Lymphoblastic Leukemia
por: Marques, Luísa Vieira Codeço, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rtcpa6fmjqi7g95j5bcukf36v0